Ka. Glatter et al., SUSTAINED VOLUME EXPANSION AND [NA,K]ATPASE INHIBITION IN CHRONIC-RENAL-FAILURE, American journal of hypertension, 7(11), 1994, pp. 1016-1025
Hypotheses regarding the pathogenesis of volume-dependent hypertension
have invoked an endogenous sodium pump inhibitor or digitalis-like fa
ctor (DLF) to link altered sodium homeostasis to the rise in blood pre
ssure. Our goal was to develop a clinical protocol that achieved predi
ctable, sustained volume expansion, with the premise that renal failur
e patients on peritoneal dialysis would increase intravascular volume,
gain weight, and raise blood pressure (BP) in relation to measured in
creases in DLF. In a 5-day protocol, dialysis was kept constant but di
etary NaCl and fluids were modified in 7 patients. DLF was measured as
inhibition of [Na,K]ATPase. Likewise, the first 2 L of daily peritone
al dialysate (PD) was processed on HPLC and the eluate analyzed for DL
F. The group achieved significant weight gain (WT) by day 3 (Delta WT
= 4.1 +/- 1.2 kg, P < .05). Likewise, mean arterial pressure (MAP) and
plasma DLF activity increased significantly. All variables were highl
y correlated (DLF v WT: R = 0.88, P = .004; MAP v DLF: R = 0.82, P = .
01; MAP v WT: R = 0.90, P = .003). Although a number of HPLC fractions
contained agents that interacted with the assay, only one PD HPLC fra
ction (at 19.5 min) contained DLF activity that correlated with change
s in MAP (R = 0.60, P = .002), and body weight (R = 0.67, P = .0003).
We conclude that candidate DLF responds to sustained volume expansion
and the relationship suggests that it could influence blood pressure.
Moreover, the application of stringent criteria to the confusing array
of factors in plasma that may affect assays for DLF appears to reduce
the field dramatically, to a single candidate in this setting.